CD160, a glycosylphosphatidylinositol-anchored Ig domain protein that is expressed on NK cells, γδ T cells and a minor subset of CD4+ and CD8+ T cells, is also overexpressed in some ESCC tumours in our study. The gene discussed is CD160; the disease is neoplasm.